ACS chemical neuroscience molecule spotlight on Saphris.

@article{Hopkins2010ACSCN,
  title={ACS chemical neuroscience molecule spotlight on Saphris.},
  author={C. Hopkins},
  journal={ACS chemical neuroscience},
  year={2010},
  volume={1 4},
  pages={
          263-4
        }
}
  • C. Hopkins
  • Published 2010
  • Psychology, Medicine
  • ACS chemical neuroscience
On August 14th, 2009, for the first time, the FDA has approved a psychotropic medication for two indications simultaneously. Saphris (asenapine) is a multitarget atypical antipsychotic medication approved to treat adults with schizophrenia and bipolar I disorder.